Molecular Innovations in Cancer
Genomics, Microbiomics Approaches
-
10% KEDVEZMÉNY?
- Kiadói listaár GBP 115.00
-
54 941 Ft (52 325 Ft + 5% áfa)
Az ár azért becsült, mert a rendelés pillanatában nem lehet pontosan tudni, hogy a beérkezéskor milyen lesz a forint árfolyama az adott termék eredeti devizájához képest. Ha a forint romlana, kissé többet, ha javulna, kissé kevesebbet kell majd fizetnie.
- Kedvezmény(ek) 10% (cc. 5 494 Ft off)
- Kedvezményes ár 49 447 Ft (47 093 Ft + 5% áfa)
49 447 Ft
Beszerezhetőség
Még nem jelent meg, de rendelhető. A megjelenéstől számított néhány héten belül megérkezik.
Why don't you give exact delivery time?
A beszerzés időigényét az eddigi tapasztalatokra alapozva adjuk meg. Azért becsült, mert a terméket külföldről hozzuk be, így a kiadó kiszolgálásának pillanatnyi gyorsaságától is függ. A megadottnál gyorsabb és lassabb szállítás is elképzelhető, de mindent megteszünk, hogy Ön a lehető leghamarabb jusson hozzá a termékhez.
A termék adatai:
- Kiadás sorszáma 1
- Kiadó CRC Press
- Megjelenés dátuma 2026. május 22.
- ISBN 9781041082118
- Kötéstípus Keménykötés
- Terjedelem264 oldal
- Méret 254x178 mm
- Nyelv angol
- Illusztrációk 41 Illustrations, color; 41 Line drawings, color; 20 Tables, black & white 700
Kategóriák
Rövid leírás:
This book offers a comprehensive overview of the latest breakthroughs transforming cancer research and treatment.
TöbbHosszú leírás:
This book offers a comprehensive overview of the latest breakthroughs transforming cancer research and treatment. Integrating insights from molecular biology, pharmacology, microbiomics, and artificial intelligence, this volume highlights how cross-disciplinary innovations are redefining oncology.
The book explores the applications of multi-omics and computational tools, the potential of heterocyclic and bioactive compounds, and the promise of probiotic-based nanomedicine in advancing personalized cancer therapy. It further examines the emerging roles of the gut microbiome, pharmacomicrobiomics, and AI-driven diagnostics in enhancing therapeutic precision and enabling early cancer detection. Addressing a wide spectrum of cancer types from colorectal and breast cancers to gliomas, the book also discusses contemporary challenges such as microplastic exposure, mitochondrial dysfunction, and the importance of evidence-based clinical practices in oncology. Beyond therapeutics, it highlights cutting-edge diagnostic innovations, including AI-assisted screening tools and microbiome-based biomarkers for early colorectal cancer detection. The volume concludes with evidence-based insights into clinical practices, such as blood transfusion protocols in oncology, effectively bridging laboratory research with real-world clinical applications.
With contributions from leading experts across disciplines, this book serves as a valuable reference for oncologists, biomedical researchers, clinicians, and students, offering a forward-looking perspective on how integrated scientific approaches are shaping the future of cancer care.
Több
Tartalomjegyzék:
Chapter 1: Multi-Omics, Computational Approaches, and AI Tools in Oncotherapeutics: Recent Advances and Perspectives. Chapter 2: Exploring Small Heterocyclic Compounds as Promising Agents in Cancer Therapy. Chapter 3: Probiotic-Based Nanomedicine: A Next-Generation Strategy for Personalized Cancer Therapy. Chapter 4: Pharmacomicrobiomics and AI designs in GI Tract Cancers. Chapter 5: Gut microbiome: a novel screening tool for colorectal cancer. Chapter 6: The Intersection of Oncology and Infectious Diseases in Human Health: The Battle Between Pathogens. Chapter 7: Artificial intelligence-integrated precision oncology of colorectal cancer. Chapter 8: Precision Medicine in Breast Cancer: An Immuno-oncology Approach. Chapter 9: Harnessing probiotics for personalized cancer therapy: A holistic approach. Chapter 10: Mitochondrial Dysfunction in Gliomas: Pathophysiological insights and Therapeutic Targets. Chapter 11: Plastic Pollution and Cancer: The Emerging Role of Microplastics in Oncology. Chapter 12: Bioactive Compounds in Personalized Colorectal Cancer Therapy: Emerging Challenges and Future Directions. Chapter 13: Evidence based blood transfusion practices.
Több
